Cerebrolysin · DOSSIER

Cerebrolysin

Cerebrolysin · FPF-1070
LEGAL DE · NOT APPROVEDEVIDENCE · EARLY CLINICAL STUDIES2 STUDIES
FIG.01 — SIGNAL CHAIN
02

Mechanism of action

What Cerebrolysin does in the body — step by step.

01

Cerebrolysin is not a single peptide but a standardised mixture of low-molecular-weight peptides and free amino acids derived from porcine brain tissue.

02

It is credited with neurotrophic and neuroprotective properties said to resemble those of the body's own neurotrophic factors.

03

Discussed effects include neuronal survival, synaptic plasticity and modulation of inflammatory and apoptotic processes.

03

Research status

How far along is the evidence?

PRECLINICALEARLY CLINICAL STUDIESCLINICALLY ESTABLISHED
Cerebrolysin is available as a medicine in several countries (mainly in Eastern Europe and Asia) but is not centrally approved in the EU.
Cerebrolysin is available as a medicine in several countries (mainly in Eastern Europe and Asia) but is not centrally approved in the EU.
It has been investigated in the context of acute ischaemic stroke, vascular dementia and traumatic brain injury.
A Cochrane review (2023) on acute ischaemic stroke found no convincing evidence of benefit on death or disability.
Overall the evidence base is considered heterogeneous and inconsistent.
04

Known risks

Without human data, safety statements are limited. What is known:

01
Heterogeneous, inconsistent evidence — benefit not convincingly demonstrated
02
Hypersensitivity and allergic reactions possible
03
Dizziness, agitation, sensation of heat described in studies
04
Biological source material (porcine brain) — theoretical contamination risk
05
Product quality cannot be verified from unapproved sources
05

Cited studies

Chronological — links lead to the source.

2023
Cerebrolysin for acute ischaemic stroke
PubMed 37818733 →
2025
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study
PubMed 39957612 →
06

Frequently asked questions

What is Cerebrolysin?+

Cerebrolysin is not a single peptide but a standardised mixture of low-molecular-weight peptides and free amino acids derived from porcine brain tissue.

What type of peptide is Cerebrolysin?+

Cerebrolysin belongs to the Neuropeptide class.

What is Cerebrolysin used for?+

In research, Cerebrolysin has primarily been investigated in the context of: Cognition, Recovery. These are research findings (evidence: early clinical studies), not proven benefits in humans and not a usage recommendation.

Is Cerebrolysin legal in Germany?+

Cerebrolysin is not approved as a medicine in Germany. Obtaining it outside clinical studies is legally problematic.

Is Cerebrolysin FDA-approved / legal in the US?+

No. Cerebrolysin is not FDA-approved as a drug in the US; it is mostly sold as a research chemical and not for human consumption.

Is Cerebrolysin legal in Canada?+

No. Cerebrolysin is not authorized by Health Canada and not intended for human consumption.

Where can I buy Cerebrolysin?+

Peptica sells nothing and names no sources. Cerebrolysin is "not approved" in Germany; obtaining unapproved substances outside clinical studies is illegal and carries quality and safety risks.

What is the dosage of Cerebrolysin?+

Peptica publishes no dosing. There are no approved dosing guidelines for Cerebrolysin; figures circulating online stem from animal studies or anecdote, not from validated human protocols. This is not medical advice.

Is Cerebrolysin banned in sport (WADA)?+

Cerebrolysin is currently not on the WADA Prohibited List.

What are the known risks of Cerebrolysin?+

Documented risks include: Heterogeneous, inconsistent evidence — benefit not convincingly demonstrated; Hypersensitivity and allergic reactions possible. This is not a complete safety assessment and not medical advice — see the risks section for the full list.

How well researched is Cerebrolysin?+

The evidence is classified as “early clinical studies”. 2 studies are cited on this page.

Which peptides are related to Cerebrolysin?+

Closely related entries: Semax, Selank. A direct side-by-side comparison is available via the compare function.

07

Dossier

Legal · Structure · Sources.

LEGAL STATUS BY REGION
Germanynot approved

Cerebrolysin is not approved as a medicine in the EU, Germany or Switzerland, although it is marketable in some other countries. Importing it into Germany without approval is problematic under medicines law. Not on the WADA Prohibited List.

Legal status varies by country and can change. This is not legal advice.

SOURCES & EXTERNAL DATABASES

Methodology: Peptica compiles publicly available studies and regulatory information and assigns each statement an evidence level. Not medical advice. No warranty.

RELATED PEPTIDES & FURTHER READING
08

Community notes

Note: These posts are user opinions and not medical advice. Posts containing dosages, therapeutic claims or purchase recommendations are removed. All entries are manually reviewed before publication.
This page is intended solely for factual, scientifically oriented information. No medical advice · no dosage or usage recommendations · no claims of efficacy · no substitute for medical consultation. Peptica sells no substances. Partner links are marked as advertising; Peptica may earn a commission. © 2026 Peptica · Issue 01